C7A.090 Malignant carcinoid tumor of the bronchus and lung

Name of the Condition

• Malignant carcinoid tumor of the bronchus and lung

Summary

Malignant carcinoid tumors of the bronchus and lung are rare neuroendocrine cancers that originate from hormone-producing cells in the airway or lung tissue. These tumors may secrete bioactive substances, leading to symptoms related to hormone imbalance. The bronchus and lung are specific primary sites for this type of malignancy.

Causes

The exact cause is often unknown, but genetic mutations and abnormal cell growth in neuroendocrine tissues are believed to play a role. Certain genetic syndromes, such as multiple endocrine neoplasia type 1 (MEN1), may contribute to their development.

Risk Factors

• Genetic predisposition: Family history of neuroendocrine tumors or inherited syndromes like MEN1.
• Age: More common in adults over 50.
• Gender: Slightly more prevalent in women.
• Tumor location: Higher incidence in the bronchus or lung compared to other sites.

Symptoms

• Persistent cough or wheezing.
• Chest pain or discomfort.
• Shortness of breath.
• Flushing or redness of the face and neck.
• Heart palpitations or rapid heartbeat.
• Unexplained weight loss and fatigue.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Blood or urine tests may detect elevated hormone levels (e.g., serotonin or chromogranin A). Imaging studies like CT, MRI, or PET scans help locate the tumor. Bronchoscopy with biopsy confirms the diagnosis by examining tissue samples.

Treatment Options

Treatment depends on the tumor's size, location, and extent. Options may include surgery to remove the tumor, radiation therapy to target cancer cells, chemotherapy to destroy remaining cancer, or targeted therapies for specific genetic mutations. Symptom management may involve medications to control hormone-related effects.

Prognosis and Follow-Up

Prognosis varies based on the tumor's stage, grade, and response to treatment. Early-stage tumors often have a better outlook. Regular follow-up with imaging and blood tests monitors for recurrence or progression. Long-term care may include managing hormonal symptoms and addressing any treatment-related side effects.

Complications

Complications can include respiratory issues from airway obstruction, metastasis to other organs, or severe hormonal imbalances. Tumors may also cause heart valve damage or intestinal problems due to hormone secretion.

Lifestyle & Prevention

While prevention is not fully established, avoiding tobacco use and maintaining a healthy lifestyle may reduce overall cancer risk. Regular medical check-ups are important for early detection in high-risk individuals.

When to Seek Professional Help

Seek medical attention if you experience persistent respiratory symptoms, unexplained weight loss, or signs of hormonal imbalance (e.g., flushing, palpitations). Prompt evaluation is crucial for early diagnosis and treatment.

Tips for Medical Coders

Document the primary site (bronchus or lung) and confirm malignancy. Ensure the code C7A.090 is used only when the tumor is confirmed as malignant and the site is specified as bronchus or lung. Include details about diagnostic methods and treatment in the medical record for accurate coding.